The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intermittent PARP inhibitor regimen in ovarian cancer (IPIROC): A proof-of-concept exploratory pragmatic study (IPIROC#02) using generic rucaparib with pharmacodynamic assessment.
 
Asima Mukhopadhyay
Employment - National Health Service UK
Consulting or Advisory Role - Cannaria Bio
Research Funding - Medgenome (Inst)
 
Tanushri Ghosh
No Relationships to Disclose
 
Daity Bhattacharjee
No Relationships to Disclose
 
Dona Chakraborty
No Relationships to Disclose
 
Sib Roy
No Relationships to Disclose
 
Atanu Bhattacharjee
No Relationships to Disclose
 
Roma Gupta
No Relationships to Disclose
 
Papiya Mukherjee
No Relationships to Disclose
 
Somoshree Sengupta
No Relationships to Disclose
 
Sharmistha Das
No Relationships to Disclose
 
Ranajit Mandal
No Relationships to Disclose
 
Puja Chatterjee
No Relationships to Disclose
 
Manisha Vernekar
No Relationships to Disclose
 
Rahul Chowdhury
No Relationships to Disclose
 
Amlan Sarkar
No Relationships to Disclose
 
IPIROC Study Group
No Relationships to Disclose